An activity pattern in certain genes responsible for building proteins known as spleen tyrosine kinases can predict which melanoma patients are likely to have severe side effects from immunotherapy designed to treat the most deadly skin cancer, a new study shows.
from News Medical Medical Research News Feed https://ift.tt/fBVPDY9
0 Comments